Specialties
Reports that name this provider
- Longevity Medicine Quality in Japan
- 13 government-approved treatment protocols, directed by Dr. Yuichi Wakabayashi (MD, PhD), board-certified by American Board of Regenerative Medicine, NIH fellowship experience, recognized by Wall Street Journal as 'Next Era Leader' in 2025, cell banking capability, remote pre-consultations via WhatsApp/email, near Osaka airport
- Regenerative Medicine Access in Japan
- Holds full membership in Medical Excellence JAPAN (MEJ) accreditation. Has 13 government-approved protocols.
- Stem Cell Therapy Availability in Japan
- 13 MHLW-approved treatment protocols for autologous adipose-derived MSCs, member of Medical Excellence JAPAN (MEJ), 30 minutes from Kansai International Airport, director is NIH-trained bilingual English/Japanese, treats Type 1 and Type 2 diabetes, prediabetes, arteriosclerosis, orthopedic conditions, cosmetic and aesthetic applications, offers cell banking, treatment packages starting at approximately USD $21,000
- Stem Cell Therapy Quality in Japan
- MHLW Type 2 certification; 13 approved treatment plans; medical director Dr. Yuichi Wakabayashi (NIH-trained); reported over 3,000 cases treated